YOLFTbeta
08

CHA Biotech Co. Ltd

085660 · KQ · Healthcare / Biotechnology

7,500.00KRW+170.00 (+2.32%)

Price History

Full chart

Market Stats

Previous Close7,330.00
Open7,400.00
Day Range7,390.00 – 7,980.00
52-Week Range7,600.00 – 23,950.00
Volume308.95K
Market Cap786.55B
P/E (TTM)0.00
Forward P/E22.22
Dividend Yield0.00%
Beta0.59
50-Day Avg8,458.00
200-Day Avg14,034.20

About

Chabiotech Co.,Ltd., a bio company, develops cell and gene therapy related to stem and immune cells in South Korea and internationally. The company provides an umbilical cord blood consignment storage for the treatment of incurable diseases; regenerative medicines, immune cell and stem cell storage services, anti-aging, and solutions for incurable diseases; medical wellness programs, comprising fitness, spa, and scupplements; and customized development, production, clinical, and commercialization services to customers with research and development, and clinical experience. It offers optimized IT system construction and operation; consulting services for development, operation, and expansion of Chaum model; and solutions for maternal-centered genome testing and personalized healthcare. In addition, the company develops immune cells, such as CBT101 for recurrent glioblastoma and solid cancer, and CBT111 and CAR-NK for solid cancer; and stem cells, including CordSTEM-DD for chronic back pain, CordSTEM-POI for premature ovarian failure, CordSTEM-ST for stroke, CBT-NPC for Parkinson's disease, and hESC-RPE for macular degeneration and Stargardt's disease. Further, it offers IVF (fertility) services; cosmetics and cosmetic raw materials; medical devices and supplies; bioinsurance storage; research services; and other services. The company was founded in 2002 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Gyu-Beom Han
  • Employees296
  • Headquarters442 Dosan-daero, Seoul, South Korea, Korea
  • Websitehttps://www.chabio.com

Leadership

  • Mr. Gyu-Beom HanPresident · b. 1961
  • Mr. Won-Seok YangPresident · b. 1957
  • Mr. Kiwon HanHead of Global Business

Financials

Income Statement

Currency: KRW2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue71.21B359.31B381.82B337.76B461.14B528.12B345.34B393.78B449.26B417.46B488.60B534.61B664.72B727.48B844.58B953.95B1.05T1.27T
Growth (%)-+404.58%+6.26%-11.54%+36.53%+14.52%-34.61%+14.03%+14.09%-7.08%+17.04%+9.42%+24.34%+9.44%+16.10%+12.95%+9.55%+21.36%
Cost of Revenue48.64B319.11B327.12B294.70B356.04B390.58B277.54B266.91B297.65B294.65B320.88B354.49B473.79B510.84B640.03B677.58B769.79B904.50B
Gross Profit------52.18B126.87B151.61B122.81B167.72B180.12B190.93B216.64B204.55B276.37B275.26B363.75B
Gross Margin------15.11%32.22%33.75%29.42%34.33%33.69%28.72%29.78%24.22%28.97%26.34%28.68%
Operating Expense------40.52B135.43B115.31B129.51B149.49B121.41B196.90B209.22B265.29B283.99B323.21B412.19B
Operating Income6.81B9.71B15.45B-40.43B48.02B11.66B-8.56B36.30B-6.70B18.23B58.71B-5.97B7.42B-60.74B-7.62B-47.95B-48.44B
Operating Margin9.56%2.70%4.05%-8.77%9.09%3.38%-2.17%8.08%-1.61%3.73%10.98%-0.90%1.02%-7.19%-0.80%-4.59%-3.82%
EBITDA---------------17.91B70.09B79.26B-32.12B
EBITDA Margin---------------2.12%7.35%7.58%-2.53%
Net Income4.46B5.44B5.11B4.02B24.45B25.45B2.85B-14.96B16.88B-46.50B24.39B46.37B-18.66B-13.97B-47.54B-8.43B-8.05B-109.88B
Net Income Margin6.26%1.51%1.34%1.19%5.30%4.82%0.83%-3.80%3.76%-11.14%4.99%8.67%-2.81%-1.92%-5.63%-0.88%-0.77%-8.66%
R&D---3.86B-15.96B1.57B3.37B8.88B9.46B6.77B12.23B13.46B13.05B14.36B14.61B15.98B24.59B
R&D as % of Total Revenue---1.14%-3.02%0.45%0.86%1.98%2.27%1.39%2.29%2.02%1.79%1.70%1.53%1.53%1.94%
Interest Expense0000000000012.74B14.92B14.53B20.87B29.10B37.17B54.85B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%2.38%2.24%2.00%2.47%3.05%3.56%4.32%

Balance Sheet

Currency: KRW2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets103.88B228.35B334.30B475.02B518.47B685.47B620.88B644.83B768.93B793.61B947.53B1.16T1.31T1.54T1.61T1.73T2.19T2.55T
Total Liabilities20.47B102.75B176.06B189.56B187.06B173.12B183.43B354.73B482.61B562.87B620.54B785.74B958.62B1.08T1.32T1.07T1.91T1.74T
Total Equity83.41B124.66B158.24B284.42B307.86B383.76B297.23B290.10B286.32B230.74B326.99B377.18B355.09B456.06B291.73B281.35B284.69B304.61B
Cash3.84B17.09B55.77B39.83B55.80B128.11B129.40B164.28B133.88B114.55B89.51B117.36B121.16B122.52B66.60B60.69B235.41B237.56B
Total Debt-------8.80B35.44B70.93B93.29B196.35B260.41B-----
Net Debt------------159.31B178.21B287.16B334.54B516.59B580.09B

Cash Flow

Currency: KRW2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-24.02B42.07B34.69B45.77B66.35B-2.57B61.86B11.29B12.01B75.38B25.24B47.00B22.23B-20.63B11.51B-49.55B-72.52B
Investing Cash Flow------10.90B-50.54B-121.87B-60.09B-138.98B-98.52B-173.38B-110.31B-95.62B-83.72B7.36B-
Financing Cash Flow42.67B-36.64B83.56B-132.21B6.37B19.49B78.52B36.93B37.78B99.67B134.41B80.12B72.68B67.88B214.04B-
Capital Expenditure12.77B17.93B25.22B25.48B30.84B27.85B45.24B31.36B34.13B36.91B78.14B107.77B126.23B115.46B128.87B74.38B98.51B152.07B
Free Cash Flow------------92.76B-82.35B-93.23B-149.50B-62.86B-148.05B-224.59B
Dividends Paid---298.87M14.88M18.62M702.58M702.58M1.99B574.08M574.08M574.08M128.79M-----
FCF to OCF------------367.51%-175.22%-419.37%724.67%-546.10%298.82%309.68%
Dividend Paid to FCF------------0.62%-0.16%-----

Earnings

Report DateNov 8, 2007Mar 11, 2008Jun 1, 2011Aug 31, 2011Nov 30, 2011Feb 29, 2012May 30, 2012Aug 29, 2012Nov 28, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Aug 14, 2014Nov 14, 2014Feb 24, 2015May 16, 2015Aug 17, 2015Nov 16, 2015Feb 29, 2016May 16, 2016Aug 15, 2016Nov 13, 2016Feb 24, 2017May 15, 2017Aug 13, 2017Nov 14, 2017Feb 28, 2018May 15, 2018Aug 16, 2018Nov 13, 2018Feb 19, 2019May 15, 2019Aug 28, 2019Nov 14, 2019Feb 26, 2020May 14, 2020Aug 13, 2020Nov 13, 2020Feb 25, 2021May 14, 2021Aug 13, 2021Nov 12, 2021Feb 28, 2022May 18, 2022Aug 12, 2022Nov 11, 2022Mar 1, 2023May 12, 2023Aug 11, 2023Dec 12, 2023Mar 29, 2024May 14, 2024Aug 13, 2024Nov 11, 2024Mar 19, 2025May 14, 2025Aug 11, 2025Nov 11, 2025Feb 27, 2026Mar 31, 2026Jun 30, 2026
EPS Estimate424.02527.82--------------------------------------------------------------
EPS Actual-33.05-1129.1718.99-34.5448.1441.7230.2026.38218.46212.71133.43281.07237.38-164.91-88.1950.56-84.1732.733.6436.09-35.79-306.7396.3879.443.78131.19-82.87-79.29-163.00-822.5119.00156.0090.0094.00-70.81856.19-38.6311.46-13.09-160.85-47.57-196.7533.78-434.06-91.4343.50-92.211.27-36.83-659.0973.93-73.6594.60-332.44-259.24-75.98458.35-452.48-346.30-981.60-162.71-237.11150.24115.26
Surprise-107.79%-313.93%--------------------------------------------------------------
TimingPre-marketPre-market-------------Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hours-Pre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hours-----------Pre-market--After-hours-After-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hours-Pre-marketPre-marketPre-marketPre-market--

Key Statistics & Ratios

Market Cap786.55B
Enterprise Value1.19T
Trailing P/E0.00
Forward P/E22.22
Price / Sales0.60
Price / Book1.78
Revenue (TTM)1.31T
Gross Profit (TTM)362.13B
EBITDA-25.29B
Profit Margin1.09%
Operating Margin-8.91%
Return on Equity-1.80%
Return on Assets-2.01%
Shares Outstanding92.97M
Shares Float72.88M
Beta0.59
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20061×
151.59Dec 27, 2006

Stock Splits

  • Apr 9, 20251106:1021
  • Jun 2, 2014825:1136
  • Dec 2, 2010861:821
  • May 6, 2008744:709